XML 23 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Condensed Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Revenue $ 54,911 $ 50,487 $ 167,119 $ 151,559
Cost of products sold 52,964 48,702 161,558 146,497
Gross margin 1,947 1,785 5,561 5,062 Close
Operating expenses:         Close
Distribution, selling, general and administrative expenses 1,282 1,179 3,762 3,567 Close
Restructuring and employee severance 53 16 106 62 Close
Amortization and other acquisition-related costs 80 74 207 216 Close
Impairments and (gain)/loss on disposal of assets, net 84 20 622 883 Close
Litigation (recoveries)/charges, net 81 (76) 29 (256) CloseClose
Total Operating Expenses 1580.0 1213.0 4726.0 4472.0 0 Close
Operating earnings 367 572 835 590 Close
Other (income)/expense, net (7) 0 (25) (5) CloseClose
Total Other Income Expenses 26.0 28.0 30.0 73.0 0.0 Close
Interest expense, net 33 28 55 78 CloseClose
Earnings/(loss) before income taxes 341 544 805 517 Close
Provision for income taxes 82 197 186 189 Close
Net earnings/(loss) 259 347 619 328 Close
Less: Net earnings attributable to noncontrolling interests (1) (2) (3) (3)
Net earnings attributable to Cardinal Health, Inc. $ 258 $ 345 $ 616 $ 325
Earnings per common share attributable to Cardinal Health, Inc.:        
Basic (in shares) $ 1.06 $ 1.35 $ 2.51 $ 1.24
Diluted (in shares) $ 1.05 $ 1.34 $ 2.49 $ 1.23
Weighted-average number of common shares outstanding:        
Basic (in shares) 243 256 245 263
Diluted (in shares) 245 258 247 264
Cash dividends declared per common share $ 0.5006 $ 0.4957 $ 1.5018 $ 1.4871